Increased T Lymphocyte Activation
- Name
- Increased T Lymphocyte Activation
- Accession Number
- DBCAT004287
- Description
Not Available
- Drugs
Drug Drug Description Ipilimumab A human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma. - Drugs & Drug Targets
Drug Target Type Ipilimumab Cytotoxic T-lymphocyte protein 4 target